NCT00442988

Prediction of NODAT After Renal Transplantation

Early Prediction of New Onset Diabetes Mellitus After Transplantation (NODAT) in Renal Transplantation: Use of Oral Glucose Tolerance Test (OGTT) and Fasting Plasma Glucose (FPG).

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 360 (planned)
• Sponsor: KU Leuven · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

A statistical analysis of the predictive value of OGTT and FPG testing executed as part of standard clinical practice after renal transplantation for the diagosis of new-onset diabetes mellitus after transplantation.

Detailed description

All patients transplanted in our department receive a formal oral glucose tolerance test (and thus also fasting plasma glucose concentration) in the first week after renal transplantation. This testing for DM or Impaired Glucose Tolerance (IGT) is part of our standard clinical protocol and data are collected prospectively in all these patients in an electronic patient medical file. The development of diabetes mellitus in all transplant patients is documented, including DM therapy.

Conditions

• Renal Transplantation

Timeline

• Start date: 2000-10-01
• Completion: 2005-10-01
• First posted: 2007-03-05
• Last updated: 2007-03-05

Locations

1 site across 1 country: Belgium